Guangzhou LBP Medicine Science & Technology Co Ltd
Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research, development, and production of pathological diagnosis products in China and internationally. The company offers pathological diagnostic reagents and ancillary equipment that consists of liquid-based cytology products, including liquid-based cytology production machines and automatic sample transfer machines; polymerase… Read more
Guangzhou LBP Medicine Science & Technology Co Ltd - Asset Resilience Ratio
Guangzhou LBP Medicine Science & Technology Co Ltd (688393) has an Asset Resilience Ratio of 18.18% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2011–2024)
This chart shows how Guangzhou LBP Medicine Science & Technology Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Guangzhou LBP Medicine Science & Technology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥238.51 Million | 18.18% |
| Total Liquid Assets | CN¥238.51 Million | 18.18% |
Asset Resilience Insights
- Good Liquidity Position: Guangzhou LBP Medicine Science & Technology Co Ltd maintains a healthy 18.18% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Guangzhou LBP Medicine Science & Technology Co Ltd Industry Peers by Asset Resilience Ratio
Compare Guangzhou LBP Medicine Science & Technology Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931 |
Medical Instruments & Supplies | 0.06% |
|
Blue Sail Medical Co Ltd
SHE:002382 |
Medical Instruments & Supplies | 5.12% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 35.75% |
|
Allmed Medical Products Co Ltd Class A
SHE:002950 |
Medical Instruments & Supplies | 3.78% |
|
Inix Technologies Holdings Bhd
KLSE:0094 |
Medical Instruments & Supplies | 0.06% |
|
Focus Point Holdings Bhd
KLSE:0157 |
Medical Instruments & Supplies | 2.30% |
|
Careplus Group Bhd
KLSE:0163 |
Medical Instruments & Supplies | 4.91% |
|
LKL International Bhd
KLSE:0182 |
Medical Instruments & Supplies | 0.38% |
Annual Asset Resilience Ratio for Guangzhou LBP Medicine Science & Technology Co Ltd (2011–2024)
The table below shows the annual Asset Resilience Ratio data for Guangzhou LBP Medicine Science & Technology Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 4.06% | CN¥55.33 Million | CN¥1.36 Billion | +0.31pp |
| 2023-12-31 | 3.75% | CN¥52.56 Million | CN¥1.40 Billion | -8.85pp |
| 2022-12-31 | 12.60% | CN¥175.54 Million | CN¥1.39 Billion | -18.11pp |
| 2021-12-31 | 30.71% | CN¥419.42 Million | CN¥1.37 Billion | +14.42pp |
| 2020-12-31 | 16.29% | CN¥210.46 Million | CN¥1.29 Billion | +0.51pp |
| 2019-12-31 | 15.78% | CN¥84.88 Million | CN¥537.96 Million | +15.63pp |
| 2013-12-31 | 0.15% | CN¥376.60K | CN¥257.13 Million | -4.16pp |
| 2012-12-31 | 4.31% | CN¥8.27 Million | CN¥191.92 Million | +3.87pp |
| 2011-12-31 | 0.43% | CN¥484.40K | CN¥111.40 Million | -- |